Is BIA-ALCL a form of breast cancer?

No. BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) is not breast cancer in the strict sense. It is a T-cell lymphoma (a cancer of the lymphatic system) that develops in the fibrous capsule surrounding the implant, not in the breast tissue itself. It is treated as a lymphoma, not as breast cancer.

Should I have my textured implants removed as a precaution?

No, preventive removal of textured implants is not recommended in the absence of symptoms. French (ANSM) and international health authorities recommend annual clinical follow-up. If you notice sudden swelling of one breast, pain, or a change in contour, consult your surgeon promptly. Do not make a decision without medical advice.

Do smooth implants carry the same risk?

No. The risk of BIA-ALCL is almost exclusively associated with macro-textured implants (in particular Allergan's Biocell surface and certain Siltex surfaces). Smooth and micro-textured implants have not shown a significant increased risk. This is one of the reasons macro-textured implants were withdrawn from the French market in 2019.

How is BIA-ALCL treated?

When detected at a localised stage (within the capsule), BIA-ALCL is successfully treated in the vast majority of cases by surgical removal of the implant and the complete capsule (total capsulectomy), without the need for chemotherapy. The cure rate is excellent (>90%) when the diagnosis is made early. In rare advanced cases, chemotherapy may be added.

Implant Safety — Medical Information

Macro-Textured Implants & BIA-ALCL

What You Need to Know If You Have Textured Implants

Since 2011, cases of a rare lymphoma — BIA-ALCL — have been reported in women with macro-textured breast implants. This topic has raised significant concern. This article provides clear, evidence-based information grounded in ANSM guidelines and scientific consensus.

Key message: BIA-ALCL is a rare, treatable, and curable condition in the vast majority of cases when detected early. Do not panic — but do not ignore warning signs.

What Is BIA-ALCL?

BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) is a rare T-cell lymphoma that develops in the fluid or fibrous capsule surrounding the breast implant — not in the breast tissue itself. It is therefore not breast cancer.

It has been linked primarily to breast implants with a macro-textured surface, in particular Allergan's Biocell surface (withdrawn from worldwide markets in 2019) and certain Mentor Siltex surfaces.

In France, the ANSM has recorded several hundred cases since surveillance began. Globally, the estimated risk varies across series from 1 case per 1,000 to 1 case per 30,000 women with macro-textured implants.

Key Facts

Type: T-cell lymphoma (not breast cancer)
Implants involved: Primarily macro-textured
Average time to onset: 8 to 10 years after placement
Prognosis if localised: Excellent (>90% cure rate)
Treatment: Implant removal + capsulectomy

Warning Signs: When to See a Doctor

If you have macro-textured implants, watch for the following signs and seek prompt medical attention if any appear:

⚠ Sudden swelling of one breast

Rapid onset of asymmetry or increased volume in one breast, typically occurring years after placement. This is the most common sign (late seroma).

⚠ Pain or sensation of tightness

Unusual discomfort around the implant, different from normal post-operative sensitivity.

⚠ Palpable mass

A nodule or thickening in or around the capsule, distinct from the implant itself.

⚠ Change in breast contour

Unusual change in the shape of one breast not related to weight change or body position.

What to Do If You Have Macro-Textured Implants

Do not panic

The absolute risk of developing BIA-ALCL remains low. The vast majority of women with macro-textured implants will never develop this condition.

See your surgeon

Annual follow-up with your plastic surgeon is recommended. They can assess the state of your implants and advise you based on your personal situation.

Know your implants

Locate the implant card provided at the time of your surgery. It shows the brand, model, and surface of your implants. If you cannot find it, your surgeon may be able to access this information through the implant registry.

Seek urgent care if symptoms appear

If you notice sudden swelling of one breast (late seroma), see your surgeon within a few days. A breast ultrasound and aspiration of the fluid will be performed for analysis.

Do not remove implants without medical advice

Preventive removal is not recommended in the absence of symptoms. If you nonetheless wish to switch to smooth implants, discuss this with your surgeon.

Frequently Asked Questions

Have all macro-textured implants been withdrawn from the market?+

In France, the ANSM suspended the marketing of certain macro-textured implants in April 2019 (in particular Allergan Biocell). This decision was subsequently followed by other countries. Micro-textured and smooth implants remain available and were not subject to the same measure.

If my surgeon placed macro-textured implants, are they responsible?+

No. At the time those implants were placed, they complied with the authorisations in force and were recommended by medical societies. The link with BIA-ALCL was established progressively from 2011 onwards, and market withdrawals did not take place until 2019. Your surgeon followed the medically accepted practices of the time.

Could my new implants also cause BIA-ALCL?+

If you had breast augmentation in France after 2019, you received smooth or micro-textured implants, which have not shown a significant increased risk of BIA-ALCL. If you are unsure about the type of your implants, consult your surgeon or locate your implant card.